Pure Global
NCT06375421

Pilot and Feasibility of MEMI for Chronic Traumatic Brain Injury

Development of Ecological Momentary Intervention for Memory in Chronic Traumatic Brain Injury: A Pilot and Feasibility Study
Vanderbilt University Medical Center·ClinicalTrials.gov·behavioralEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Traumatic Brain Injury
Drug/Device/Intervention
MEMI (Memory Ecological Momentary Intervention) Spaced Retrieval
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Vanderbilt University Medical Center
Location
Nashville, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 03, 2024
End date
Dec 31, 2024
Enrollment
40 participants
Primary outcome

Acceptability,Feasibility (Engagement)

Summary

This is a pilot and feasibility study for a mobile phone-delivered intervention for memory,
 called MEMI (memory ecological momentary intervention), that was designed to support adults
 with chronic traumatic brain injury with their memory. The goal of the study is to examine
 the feasibility and acceptability of MEMI and to assess preliminary efficacy as to whether
 technology-delivered spaced memory retrieval opportunities improve memory in people with and
 without a history of chronic traumatic brain injury.

ICD-10 classifications
Diffuse brain injuryIntracranial injuryFocal brain injuryIntracranial injury, unspecifiedOther intracranial injuries
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06375421
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06375421 through Pure Global AI's free database. This phase not specified trial is sponsored by Vanderbilt University Medical Center and is currently Enrolling by invitation. The study focuses on Traumatic Brain Injury. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.